Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Arsenic toxicology: five questions.

Aposhian HV, Aposhian MM.

Chem Res Toxicol. 2006 Jan;19(1):1-15. Review. No abstract available.

PMID:
16411650
2.

Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.

Flora SJ, Bhadauria S, Pant SC, Dhaked RK.

Life Sci. 2005 Sep 16;77(18):2324-37.

PMID:
15964026
3.

Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid.

Tadlock CH, Aposhian HV.

Biochem Biophys Res Commun. 1980 May 30;94(2):501-7. No abstract available.

PMID:
6249288
4.

Reversal of arsenic-induced hepatic apoptosis with combined administration of DMSA and its analogues in guinea pigs: role of glutathione and linked enzymes.

Mishra D, Mehta A, Flora SJ.

Chem Res Toxicol. 2008 Feb;21(2):400-7. doi: 10.1021/tx700315a. Epub 2007 Dec 29.

PMID:
18163546
5.

Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.

Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH.

Int J Clin Pharmacol Ther. 2007 Mar;45(3):188; author reply 189-90. No abstract available.

PMID:
17416115
6.
7.

The role of chelation in the treatment of arsenic and mercury poisoning.

Kosnett MJ.

J Med Toxicol. 2013 Dec;9(4):347-54. doi: 10.1007/s13181-013-0344-5. Review.

8.

Fatal mercury poisoning and chelating agents.

Guzzi G, Minoia C, Ronchi A, Pigatto P.

Forensic Sci Int. 2010 Oct 10;202(1-3):e61. doi: 10.1016/j.forsciint.2010.04.048. No abstract available.

PMID:
20537473
9.

DMSA, DMPS, and DMPA--as arsenic antidotes.

Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E.

Fundam Appl Toxicol. 1984 Apr;4(2 Pt 2):S58-70.

PMID:
6327446
10.

Unanswered questions in metal chelation.

Kosnett MJ.

J Toxicol Clin Toxicol. 1992;30(4):529-47. Review. No abstract available.

PMID:
1331492
11.

Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.

Park SH.

J Gastroenterol Hepatol. 2005 Dec;20 Suppl:S20-1. Review. No abstract available.

PMID:
16359345
12.

Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.

Hsu CA, Aposhian HV, Heydolph S, Parr W.

J Pharmacol Exp Ther. 1983 Feb;224(2):314-8.

PMID:
6687396
13.

Influence of glutathione chemical effectors in the response of maize to arsenic exposure.

Requejo R, Tena M.

J Plant Physiol. 2012 May 1;169(7):649-56. doi: 10.1016/j.jplph.2012.01.016. Epub 2012 Mar 12.

PMID:
22418430
14.

Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review.

Flora SJ, Bhadauria S, Kannan GM, Singh N.

J Environ Biol. 2007 Apr;28(2 Suppl):333-47. Review.

PMID:
17929749
15.

Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis.

Bachus R, Neubert K, Roots I, Prudlo J, Brockmöller J, Ludolph AC.

J Neurol Neurosurg Psychiatry. 2003 Aug;74(8):1161. No abstract available.

16.

Arsenic binding to proteins.

Shen S, Li XF, Cullen WR, Weinfeld M, Le XC.

Chem Rev. 2013 Oct 9;113(10):7769-92. doi: 10.1021/cr300015c. Epub 2013 Jun 28. Review. No abstract available.

17.

2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.

Hruby K, Donner A.

Med Toxicol Adverse Drug Exp. 1987 Sep-Oct;2(5):317-23. Review. No abstract available.

PMID:
3312928
18.

DMSA and DMPS--water soluble antidotes for heavy metal poisoning.

Aposhian HV.

Annu Rev Pharmacol Toxicol. 1983;23:193-215. Review. No abstract available.

PMID:
6307120
19.

Dose of proton pump inhibitors and the CYP2C19 genotype.

Bertilsson L.

Basic Clin Pharmacol Toxicol. 2004 Jul;95(1):1. No abstract available.

20.

Arsenic and copper excretion after treatment of arsenic poisoning in rats with heavy-metal antagonists.

Maehashi H, Yamaguchi Y, Tsutsumi S.

Dev Toxicol Environ Sci. 1983;11:325-8. No abstract available.

PMID:
6329629

Supplemental Content

Support Center